Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly composition-dependent. Area percent at one wavelength is not area percent at the other.
Detection wavelength and why 214 nm and 280 nm disagree posts 61–85
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Where I part company with post #58, and it is a narrow parting.
Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of higher back pressure. Newer methods increasingly use smaller particles.
I am reporting what happened, not recommending it.
Agreed on detection wavelength, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the starting assumption is the part nobody states.
Building on post #64 rather than restating it.
A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table if the number matters.
One more caveat and then I will stop qualifying: the sample selected itself.
Post #62 put the caveat in the right place and I want to underline it.
Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because different species absorb differently at different wavelengths. With the method stated, I can tell you something useful. Without it, all I can say is that there is one large peak.
I would want the raw data before agreeing with my own summary of it.
Taking post #67 at face value and following it one step further.
Reading back through the detection wavelength threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems like a documentation gap rather than a knowledge gap.
Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an impurity from the parent peak will not detect that impurity.
Where I part company with post #69, and it is a narrow parting.
What I want from this detection wavelength thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible peaks and gives a lower purity figure. Both are legitimate methods and they will not produce the same number.
The answer changed when I changed how I was measuring, which was informative.
Thank you — that answers what I came here to find out.
Adding the measurement that post #73 says would settle it.
The thing about detection wavelength that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation is usually good. For structurally dissimilar impurities it can be poor.
On post #77 — agreed on the reasoning, with one qualification.
Two questions I would want answered before drawing anything from the detection wavelength data above: how were the cases selected, and what happened to the ones that dropped out.
Picking up post #77: that is the part I would want checked first.
On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a chromatogram with a trailing shoulder or a rising baseline it matters. Differences of one to two percentage points between defensible integrations are ordinary.
That is the honest state of it as of this week.
Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280 it sees aromatic residues, so a peptide without tryptophan or tyrosine will look very different or not appear at all.
The variance between people here is larger than the effect being discussed.
This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong.
Written in the hope of being told what I have missed.
Taking post #82 at face value and following it one step further.
Reading this detection wavelength thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Post #80 and I disagree about the size of the effect, not about the direction.
On detection wavelength, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Collapsed as off-topic by two members at trust level 3 or above
System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was analysed. If suitability did not pass, the sample results from that run are uninterpretable.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Resolution and tailing factor: real acceptance criteria
Posting this under the heading it deserves: Resolution and tailing factor: real acceptance criteria Everything below is what sits behind that. Reading back through what has been written here about Resolution…
|
+93 | 112 | 5.7k | 9mo |
|
Area percent versus weight percent: the confusion that causes most arguments — what changed since
Area percent versus weight percent: the confusion that causes most arguments — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the…
|
+30 | 34 | 40k | 13mo |
|
Coming back to: Column chemistry choices for a 40-residue peptide
On the subject in the title: Column chemistry choices for a 40-residue peptide Working notes rather than a conclusion. Column chemistry choices — I have the observation and I do not trust my interpretation of…
|
2 | 43k | 16mo | |
|
Resolution and tailing factor: real acceptance criteria
Resolution and tailing factor: real acceptance criteria Writing it up because I had to work it out twice and would rather nobody else did. Asking about resolution and tailing factor on behalf of the question…
|
2 | 15k | 1mo | |
|
System suitability injections: if they failed, the run did not happen
Posting this under the heading it deserves: System suitability injections: if they failed, the run did not happen Everything below is what sits behind that. Proposing that system suitability injections…
|
+23 | 27 | 6k | 11mo |
Related topics — sharing the tags peak integration, UV & DAD detection, system suitability
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What a stability-indicating method is and how you demonstrate one — one year on
What a stability-indicating method is and how you demonstrate one — one year on I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about stability-indicating…
|
+100 | 112 | 15k | 19mo |
|
What a reversed-phase purity number actually is
The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I repeat…
|
+87 | 101 | 27k | 4h |
|
Seven-day rolling means and why weekly readings mislead
Seven-day rolling means and why weekly readings mislead Writing it up because I had to work it out twice and would rather nobody else did. Posting a series rather than a conclusion, with the method first.…
|
+109 | 125 | 42k | 10h |
|
A plateau that disappeared when I changed how I measured — the long version
A plateau that disappeared when I changed how I measured — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about plateau, deliberately narrow, because…
|
+49 | 54 | 9.4k | 1mo |
|
Comparing my trajectory with the trial curves, carefully — a second dataset
Comparing my trajectory with the trial curves, carefully — a second dataset — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that…
|
+77 | 81 | 16k | 11h |